Grants 2020-2025
Grants awarded during the Integrative Cancer Epidemiology Programme funding period 2020-2025, with ICEP members as principal or co-investigators:
Awarded in 2020
- Dr Siddhartha Kar: UK Research Innovation Future Leaders Fellowship "Mapping tumour molecular mechanisms associated with common exposures: a new approach to identifying targets to prevent and treat cancer" (October 2020 - September 2024)
- Dr Sarah Lewis: World Cancer Research Fund "Appraising causal mechanisms underpinning the link between physical activity and cancer risk" (November 2020 - October 2023)
- Dr Kostas Tsilidis: World Cancer Research Fund "Identifying mechanistic pathways linking diet to colorectal cancer" (November 2020 - October 2024)
Awarded in 2021
- Dr Pau Erola: Jean Golding Institute Seed Corn Funding "Pilot assessment of cancer risk after SARS-COV-19" (February 2021 - March 2021)
- Dr Emma Vincent: Elizabeth Blackwell Institute (EBI) Research Strand “Integrating Health Research: Mechanisms to Populations” (February 2021 – January 2023)
- Prof Richard Martin: NIHR “14th National Institute for Health Research (NIHR) Senior Investigator competition” (April 2021 – March 2025)
- Dr Mark Gormley: Royal College of Surgeons of England – British Association of Oral Surgeons “Establishing a DNA methylation profile for e-cigarette exposure in oral and oropharyngeal cancer cells” (June 2021 – June 2022)
- Dr Vanessa Tan: University of Bristol Cancer Research Fund "Exploring the mechanisms linking acetate and breast cancer" (July 2021 - July 2022)
- Dr Philip Haycock: University of Bristol Cancer Research Fund “Understanding the mechanism linking polyunsaturated fatty acid desaturase activity to risk of colorectal cancer” (July 2021 - July 2022)
- Dr Jess Bourne: Faculty of Social Sciences and Law (UoB) Strategic Research Funding "Strategic Research Funding for the first UK e-bike research network meeting" (December 2021 - July 2022)
Awarded in 2022
- Dr Hannah Sallis: Cancer Research UK “Smoking behaviours and transitions to vaping in early adulthood: Investigating predictors with longitudinal data” (January 2022 – December 2023)
- Dr Kaitlin Wade: Cancer Research UK Population Research Postdoctoral Fellowship “Applying human genetics to interrogate the role of the human gut microbiome in cancer aetiology” (January 2022 – December 2024)
- Dr Philip Haycock: NIHR Bristol Biomedical Research Centre: Director’s Fund 2020/21 “Mendelian randomization study of eicosanoid metabolism and colorectal cancer risk” (February 2022 – May 2022)
- Dr Pau Erola: World Cancer Research Fund “Automating WCRF/ AICR CUP systematic review processes” (March 2022 – March 2025)
- Dr Neciah Dorh: Innovate UK “Simple and Effective Screening tool for supporting early detection of brain cancer” (April 2022 – March 2024)
- Mr Kevin Liang: Canadian Institutes of Health Research "Doctoral Research Award : Priority Announcement - Primary Prevention of Cancer" (May 2022 - April 2025)
- Dr Pilar Acedo: Cancer Research UK “EPIC DIVE - Early PancreatIc Cancer Diagnosis In Vivo Evaluation” (July 2022 – December 2023)
- Dr Paolo Bertoncello: Cancer Research UK "Towards a ‘toothbrush’ sensor for passive biomarker monitoring - "Sens Or Pass"" (October 2022 - February 2024)
- Dr Kaitlin Wade: Kidney Research UK PhD Studentship “Exploring the role of the human microbiome in diabetic kidney disease” (October 2022 – April 2026)
- Dr Neil Ryan: Academy of Medical Sciences "MicrosatEllite Womb Surveillance (MEWS) study" (November 2022 - August 2023)
- Prof Jonathan Sterne: National Institute for Health and Care Research "Bristol Biomedical Research Centre" (December 2022 - November 2027)
Awarded in 2023
- Dr Jasmine Khouja: Research England QR Policy Support Fund (QR PSF) "Informing Evidence-based Policies And Interventions To Responsibly Reduce E-cigarette Use Among Youth" (January 2023 -December 2024)
- Dr Emma Allott: World Cancer Research Fund International “Periprostatic adipose tissue and aggressive prostate cancer risk: a prospective study” (March 2023 – February 2027)
- Prof George Davey Smith: Medical Research Council "Integrative Epidemiology Unit" (April 2023 - March 2028)
- Dr Tom Dudding: Cancer Research UK "Head and neck 5000 – Identifying factors affecting survival and secondary physical effects of treatment at 10 years" (April 2023 - March 2026)
- Prof Nic Timpson: Cancer Research UK “Role of directly measured metabolic profile as an intermediate between adiposity and endometrial cancer: triangulation of evidence from independent sources.” (May 2023 – April 2026)
- Dr James Yarmolinsky: Cancer Research UK’s Early Detection and Diagnosis Research Committee "Using reverse Mendelian randomization to discover novel circulating biomarkers for early detection of cancer" (June 2023 - May 2024)
- Dr Rahul Bhatnagar: MRC & NIHR "Epigenomic Methods to Improve Personalised Treatment in Patients with Lung Cancer and Malignant Pleural Effusion" (July 2023 - December 2026)
- Prof Richard Martin: Cancer Research UK Prevention & Population Research Committee "Answering key questions needed to inform prostate cancer screening policy: long-term follow-up of the ProtecT (15-year) and CAP (18-year) randomised controlled trials" (August 2023 - January 2027)
- Dr Miranda Armstrong: NIHR "HEaLth iMpact of E-bikes and e-scooTers (HELMET): Baseline data collection for the evaluation of e-bike and e-scooter hire schemes" (August 2023 - October 2024)
- Dr Angela Attwood: University of Bristol Cancer Research Fund “Co-designing smoking cessation support within NHS Targeted Lung Health Checks" (September 2023 - July 2024)
- Dr James Yarmolinsky: Cancer Research UK Prevention & Population Research Committee "Obesity and pancreatic cancer risk: leveraging genetic, observational, and molecular approaches to provide novel insights into causal intermediates to inform cancer prevention" (October 2023 - September 2026)
- Dr Becky Foster: Kidney Research UK "Adiponectin receptor agonists prevent the development of kidney disease through protection of the glomerular endothelial glycocalyx" (October 2023 - September 2026)
- Dr Rachel Barker: Prostate Cancer UK "Novel Treatment for Prostate Cancer by repurposing Alzheimer Drugs: determining the role of amyloid precursor protein" (October 2023 - September 2026)
Awarded in 2024
- Dr Kate Ruth: UKRI "Using genetics to understand the role of hormones in postmenopausal health" (January 2024 - January 2029)
- Dr Anna Murray: MRC "Improving future treatment options for menopausal symptoms by using genomics to understand aetiology" (March 2024 - March 2027)
- Dr Christos Chalitsios: WCRF "Impact of sleep on the development of reproductive system cancers" (March 2024 - February 2025)
- Dr Hannah Sallis: University of Bristol, Bristol Digital Futures Institute "Making Exercise More Effective (MEME) - incorporating wearable technology within Healthy Minds" (September 2024 - August 2025)
- Dr Faezeh Arab Hassani: Cancer Research UK "TACIMApatch: Tactile imaging patch for early detection of breast tumours" (September 2024 - August 2025)
- Dr Miranda Armstrong: ESRC "Recovering from Cancer while riding an electric bike" (July 2024 - November 2024)
- Dr Rebecca Beeken and Prof John Saxton: NIHR "Preparing to develop and test an equitable weight management intervention to improve outcomes for seldom reached groups affected by breast cancer: FOR ALL" (October 2024 - September 2025)
- Dr Helena Carreira: Cancer Research UK "Associations between androgen deprivation therapies and adverse cardiovascular outcomes in men with prostate cancer: a population-based cohort study in England" (September 2024 - August 2027)
- Dr Emma Vincent: Cancer Research UK "Does the biological response to ketogenesis influence colorectal cancer risk? – Exploring causality and mechanism" (December 2024 - May 2027)
- Dr Emma Vincent: WCRF "How does adiposity distribution influence risk of obesity-related cancers? - Exploring causality and mechanisms" (January 2025 - January 2028)
- Dr Tyler Seibert: Prostate Cancer Foundation Challenge Awards "Germline genomic and clinical predictors of prostate cancer outcomes and treatment toxicity in the ProtecT randomized trial" (December 2024 - November 2026)